What question did this study set out to answer?

The research aims to explore the variability in albuminuria reduction among individuals taking dapagliflozin.

April 4, 2026Balkan Medical JournalOpen Access

Reduction in Albuminuria with Dapagliflozin Exhibits Substantial Interindividual Variability: A Real-World Study Utilizing a Big Data Approach

View Full Paper

Ask AI

Bookmark

Authors

A real-world study shows variability in albuminuria reduction from dapagliflozin in a Chinese population, indicating factors influencing this effect.

The research aims to explore the variability in albuminuria reduction among individuals taking dapagliflozin.
Conducted a real-world study utilizing big data analysis
Analyzed factors such as duration of T2DM, baseline HbA1c, SBP, and UACR
Performed ROC analysis to assess discriminative ability of identified factors
Notable interindividual variability in albuminuria-lowering effect of dapagliflozin
Duration of T2DM, baseline HbA1c, SBP, and UACR associated with the response
ROC analysis indicated limited discriminative ability for clinical use

Song et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

A real-world study shows variability in albuminuria reduction from dapagliflozin in a Chinese population, indicating factors influencing this effect.